Is 4503.T up or down today?
4503.T is up 1.42% today, last at 23.73. This stock moved +1.42% versus the prior close.
4503.T · 4503.T
4503.T (4503.T) is trading at 23.73, up 1.42% on the session. 4503.T sits at the 50% mark of its 52-week range, carries a 14-day RSI of 46, and trades below its 50-day average. Over the past month it is down 1.36%.
Leading the coverage: “AI Proteins Announces Research Collaboration and License Agreement With Astellas Pharma to Discover and Develop Novel Miniprotein-Based Therapeutics Valued at Over $400 Million” (Yahoo Finance, 10d ago). 4503.T is +1.14% since story.
4503.T trades on a trailing P/E of 37.0 and is running 0.28% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
4503.T is up 1.42% today, last at 23.73. This stock moved +1.42% versus the prior close.
Leading the coverage: “AI Proteins Announces Research Collaboration and License Agreement With Astellas Pharma to Discover and Develop Novel Miniprotein-Based Therapeutics Valued at Over $400 Million” (Yahoo Finance, 10d ago). 4503.T is +1.14% since story. Dominant story: 4503.T in focus ahead of earnings next week (1 source, neutral) RSI is 46 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Oct 2026 (181 days) · Drag or scroll left for earlier dates
4503.T in focus ahead of earnings next week
Why 4503.T could be a long-term compounder
4503.T faces regulatory scrutiny over new product
Astellas Pharma Inc. (4503.T) stock price, news, quote and history - Yahoo Finance Singapore
Astellas and Audax Biosciences Enter Exclusive Option and License Agreement for DAX-044, a Novel Immune-Targeted IL-12 Antibody-Cytokine Fusion for Immuno-Oncology